Phreesia, Inc. (NYSE:PHR) CFO Sells $132,261.24 in Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 4,813 shares of the stock in a transaction dated Monday, January 27th. The stock was sold at an average price of $27.48, for a total value of $132,261.24. Following the completion of the sale, the chief financial officer now owns 144,933 shares of the company's stock, valued at $3,982,758.84. This trade represents a 3.21 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Price Performance

Phreesia stock traded down $0.53 during mid-day trading on Friday, reaching $28.47. 306,682 shares of the company were exchanged, compared to its average volume of 388,179. The company has a fifty day simple moving average of $24.98 and a 200-day simple moving average of $23.28. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.90. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a market cap of $1.65 billion, a PE ratio of -19.37 and a beta of 0.94.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same quarter last year, the company earned ($0.58) EPS. The company's revenue was up 16.6% on a year-over-year basis. As a group, equities research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Needham & Company LLC reiterated a "buy" rating and set a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. KeyCorp increased their price objective on Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a report on Wednesday, January 8th. Piper Sandler reissued an "overweight" rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a research report on Wednesday. Truist Financial increased their price target on Phreesia from $31.00 to $34.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Finally, JMP Securities reissued a "market outperform" rating and set a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $31.15.

Hedge Funds Weigh In On Phreesia

A number of hedge funds have recently added to or reduced their stakes in the stock. Hsbc Holdings PLC bought a new stake in shares of Phreesia during the 2nd quarter worth $301,000. Sei Investments Co. raised its stake in Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company's stock worth $3,505,000 after acquiring an additional 95,058 shares in the last quarter. Squarepoint Ops LLC lifted its holdings in shares of Phreesia by 56.3% in the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company's stock worth $5,308,000 after acquiring an additional 90,215 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Phreesia during the 3rd quarter valued at approximately $954,000. Finally, Diversified Trust Co increased its position in Phreesia by 12.9% during the 3rd quarter. Diversified Trust Co now owns 24,356 shares of the company's stock worth $555,000 after purchasing an additional 2,782 shares in the last quarter. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.